Work

Expression and therapeutic potential of TROP-2 in Cisplatin-resistant non-seminomatous germ cell tumors

Year: 2025

Type: conference-paper

Abstract: Background: Cisplatin-based chemotherapy has been the standard of care for metastatic germ cell tumors (mGCT) for the past four decades due to its high efficacy. However, cisplatin-refractory patients have a poor prognosis due to limited treatment options. Therefore, there is an unmet need for effective [for full text, please go to the a.m. URL]

Source: German Medical Science (German Research Foundation)

DOI: 10.3205/25nrwgu24

Authors: Sperber, Laurenz, von Brandenstein, Melanie, Kessler, Carolina, Storz, Enno, Pfister, David, Paffenholz, Pia, Tolkach, Yuri, Bernhardt, Marit, Eckstein, Markus, Nestler, Tim, Wirtz, Ralph, Krausewitz, Philipp, Klümper, Niklas, Heidenreich, Axel, Weiten, Richard

Institutions: University Hospital Cologne, University Hospital Bonn, Universitätsklinikum Erlangen, Bundeswehrzentralkrankenhaus Koblenz

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6889899214

FWCI:

Cites:

Cited by:

Related to: